Physical exercise may provide protection against the cognitive decline and neuropathology associated with Alzheimer's disease, although the mechanisms are not clear. In the present study, APP/PSEN1 double-transgenic and wild-type mice were allowed unlimited voluntary exercise for 7 months. Consistent with previous reports, wheel-running improved cognition in the double-transgenic mice. Interestingly, the average daily distance run was strongly correlated with spatial memory in the water maze in wild-type mice (r 2 = .959), but uncorrelated in transgenics (r 2 = .013). Proteomics analysis showed that sedentary transgenic mice differed significantly from sedentary wild-types with respect to proteins involved in synaptic transmission, cytoskeletal regulation, and neurogenesis. When given an opportunity to exercise, the transgenics' deficiencies in cytoskeletal regulation and neurogenesis largely normalized, but abnormal synaptic proteins did not change. In contrast, exercise enhanced proteins associated with cytoskeletal regulation, oxidative phosphorylation, and synaptic transmission in wild-type mice. Soluble and insoluble Aβ40 and Aβ42 levels were significantly decreased in both cortex and hippocampus of active transgenics, suggesting that this may have played a role in the cognitive improvement in APP/PSEN1 mice. β-secretase was significantly reduced in active APP/PSEN1 mice compared to sedentary controls, suggesting a mechanism for reduced Aβ. Taken together, these data illustrate that exercise improves memory in wild-type and APP-overexpressing mice in fundamentally different ways. © 2015 Elsevier Inc. All rights reserved.
Introduction
Alzheimer's disease is the most common form of dementia, characterized by plaques of misfolded amyloid β (Aβ), neurofibrillary tangles of hyperphosphorylated tau, widespread neurodegeneration, and loss of cognitive and other functions. Considerable evidence now supports the notion that factors affecting cardiovascular function may also affect the symptoms and severity of Alzheimer's disease. Indeed, obesity, glucose intolerance, and high cholesterol are all considered risk factors for Alzheimer's disease. Inversely, evidence suggests that physical exercise may improve memory in Alzheimer's patients and perhaps slow cognitive decline. Taken together, these results suggest that metabolic factors may play a significant role in Alzheimer's dementia.
Like Alzheimer patients, transgenic mice that overexpress mutant human amyloid precursor protein (APP) typically show improved memory when given the opportunity to exercise. The improved cognition is usually accompanied by reductions in Aβ and amyloid plaques. However, improvements in memory and pathology are not always observed, and there is little understanding of how exercise-induced changes may come about. Adlard et al. (2005) observed a substantive reduction in plaque load and total Aβ in 6-month-old TgCRND8 mice given the opportunity for voluntary wheel-running for 5 months. However, they did not observe changes in APP, α-, β-, or γ-secretase activity, APP C-terminal fragments (CTFs), or degradative enzymes. They repeated the study in a separate group of mice given access to running wheels for only 1 month, starting at 6 weeks of age. Again, Aβ was reduced in the presence of normal levels of APP, secretase activity, insulin degrading enzyme (IDE), and neprilysin. However, this time α-and β-CTFs were significantly reduced. They concluded that transient changes in APP processing occurred early in the exercise routine, resulting in long-lasting reductions in Aβ. In contrast, Maesako et al. 
